Get Instant Summarized Text (Gist) The FDA has approved vimseltinib (Romvimza) for treating tenosynovial giant cell tumor (TGCT), a non-cancerous joint tissue tumor. In a Phase III trial, 67% of ...

The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

Dr. William Tap led the development of vimseltinib for tenosynovial giant cell tumor. The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare ...

Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR 999077, People’s Republic of China Department of Chemistry, National University of ...

4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells ... A team of stem cell scientists have ...

Get Instant Summarized Text (Gist) The CLEAR study highlights the importance of tumor size reduction in enhancing survival outcomes for advanced renal cell carcinoma (aRCC) patients. The ...

Malignant tumors grow rapidly, while benign brain tumors tend to grow more slowly. Though benign tumors are generally less worrisome when they occur in other parts of the body, in the brain, they ...

LONDON, March 14 (Reuters) - Spirits giant Diageo (DGE.L), opens new tab has suggested the U.S. government consider tougher rules of origin requirements in trade agreements as an alternative to ...

Feb 27 (Reuters) - Chilean industrial conglomerate Empresas Copec (COPEC.SN), opens new tab on Thursday posted a profit for the last three months of 2024 that rose 15% thanks to larger pulp ...

According to experts, the giant Large Phased Array Radar (LPAR) in Yunnan is an advanced early-warning system that can detect and track ballistic missile launches within a radius of 5000 ...